TIMING AND DURATION OF ADMINISTRATION OF ADENOSINE A1/A2 AGONIST FOR CARDIOPROTECTION - Patent 1387686

(19)

(11)

EP 1 387 686 A1

(12)

(43)	Date of publication:
	11.02.2004 Bulletin 2004/07

(21)	Application number: 02734215.3

(22)	Date of filing: 03.05.2002

(51)	International Patent Classification (IPC)⁷: A61K 31/519, A61P 9/10

(86)	International application number:
	PCT/US2002/014228

(87)	International publication number:
	WO 2002/089807 (14.11.2002 Gazette 2002/46)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

04.05.2001 US 288936 P
17.08.2001 GB 0120124

(71)	Applicant: Aventis Pharmaceuticals Inc.
	Bridgewater, New Jersey 08807-2854 (US)

(72)	Inventors:
	XU, Zhelong Chapel Hill, NC 27514 (US) DOWNEY, James, M. Mobile, AL 36693 (US)

(74)	Representative: Fischer, Hans-Jürgen
	Aventis Pharma Deutschland GmbH,Patent- und Lizenzabteilung,Industriepark Höchst, K 801 65926 Frankfurt am Main 65926 Frankfurt am Main (DE)

(54)	TIMING AND DURATION OF ADMINISTRATION OF ADENOSINE A1/A2 AGONIST FOR CARDIOPROTECTION